The impact of Xpert® MTB/RIF depends on service coordination: experience in Burkina Faso

Int J Tuberc Lung Dis. 2015 Mar;19(3):285-7. doi: 10.5588/ijtld.14.0629.

Abstract

Translating the potential of Xpert(®) MTB/RIF into more effective tuberculosis (TB) care and control in low-income settings is challenged by operational issues. We report the experience in introducing this technology in Burkina Faso through a centralised approach. Xpert was successfully integrated into the diagnostic algorithm of multidrug-resistant TB cases. However, barriers to Xpert use for the diagnosis of TB in vulnerable populations, such as persons living with human immunodeficiency virus infection and children, were observed, mainly due to lack of coordination between services. Lessons learnt can be exploited to optimise the roll-out of this technology at country level.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Burkina Faso
  • Drug Resistance, Multiple, Bacterial
  • Feasibility Studies
  • HIV Infections
  • Humans
  • Molecular Diagnostic Techniques / methods*
  • Mycobacterium tuberculosis / isolation & purification
  • Nucleic Acid Amplification Techniques / methods*
  • Sputum / microbiology
  • Tuberculosis, Multidrug-Resistant / diagnosis*
  • Tuberculosis, Multidrug-Resistant / therapy
  • Tuberculosis, Multidrug-Resistant / virology